Davis's Drug Guide
inavolisib
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
in-a-voe-lis-ib
Trade Name(s)
- Itovebi
Ther. Class.
Pharm. Class.
kinase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Inavolisib." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580051/5/inavolisib.
Vallerand AHA, Sanoski CAC, . Inavolisib. Davis's Drug Guide. F.A. Davis Company; 2025. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580051/5/inavolisib. Accessed April 16, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Inavolisib. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580051/5/inavolisib
Vallerand AHA, Sanoski CAC, . Inavolisib [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 April 16]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580051/5/inavolisib.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - inavolisib
ID - 3580051
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580051/5/inavolisib
PB - F.A. Davis Company
ET - 19
DB - Emergency Central
DP - Unbound Medicine
ER -
